COURTNEY FRAME: Open Payments
NPI 1790453397 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 25 payments from 16 companies in 2025. Trend: 2023 $90 · 2024 $824 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $322 |
| Boston Scientific Corporation | 1 | $153 |
| AstraZeneca Pharmaceuticals LP | 3 | $145 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $99 |
| ABIOMED | 3 | $74 |
| CVRx, Inc. | 2 | $64 |
| Amgen Inc. | 1 | $60 |
| BridgeBio Pharma, Inc. | 2 | $41 |
Products named: SAPIEN 3 Ultra RESILIA, WATCHMAN, FARXIGA, EVKEEZA, Ozempic, AMVUTTRA, Barostim Neo System, Repatha.
Industry payments across NY — which companies pay providers there.
